Zevalin ibritumomab tiuxetan (IDEC-Y2B8): Phase III testing udpate

Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif.
Product: Zevalin ibritumomab

Read the full 101 word article

How to gain access

Continue reading with a
two-week free trial.